Hyperrho S/d Full Dose Generic Name & Formulations
Rho(D) immune globulin human 1500 IU; per syringe; soln for IM inj; preservative-free; latex-free.
Full dose (Single-dose prefilled syringe)—1; Mini dose (Single-dose prefilled syringe)—10
Hyperrho S/d Full Dose Indications
Prevention of isoimmunization in non-sensitized Rho(D) negative women during pregnancy and in appropriate obstetrical conditions, unless the fetus or father is known to be Rho(D) negative. Prevention of isoimmunization in Rho(D) negative individuals transfused with Rho(D) positive blood products.
Hyperrho S/d Full Dose Dosage and Administration
See literature. Give IM only. Pregnancy (28 weeks gestation), postpartum prophylaxis (within 72 hours), obstetric complications, invasive procedures during pregnancy: 1500IU. Incompatible transfusions (within 72 hours): volume of red blood cells transfused divided by 15mL provides the number of syringes to be administered; if the dose is a fraction, round to next higher whole number of syringes.
Hyperrho S/d Full Dose Contraindications
Hyperrho S/d Full Dose Boxed Warnings
Hyperrho S/d Full Dose Warnings/Precautions
Contains human plasma; monitor for possible infection transmission. IgA deficiency. Pregnancy (Cat.C).
Hyperrho S/d Full Dose Pharmacokinetics
Hyperrho S/d Full Dose Interactions
Avoid live vaccines within 3 months.
Hyperrho S/d Full Dose Adverse Reactions
Local or infusion reactions.
Hyperrho S/d Full Dose Clinical Trials
Hyperrho S/d Full Dose Note
Report all infections suspected to be transmitted by HyperRHO S/D to (800) 520-2807.
Hyperrho S/d Full Dose Patient Counseling